Skip to content

HNGE HNGE Investing Cash Flow

Investing Cash Flow at other companies

Globus Medical logo
Globus MedicalGMED
-$182.67M-239%
Hims & Hers Health logo
Hims & Hers HealthHIMS
-$15.45M+52.9%
Stryker logo
StrykerSYK
-$185M+95.5%
Solventum logo
SolventumSOLV
-$77M+32.5%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
-$159M-50.0%
Medtronic logo
MedtronicMDT
-$917M-87.1%

Other financials

Income statement

See full
Revenue$182.3M+47.2%
Gross profit$154.2M+53.9%
Operating income$32.1M+144%
Net income$35.1M+105%
EPS (diluted)$0.41-68.7%

Balance sheet

See full
Cash & equivalents$188.1M-35.2%
Total debt$7.0M
Total equity$111.7M+136%
Total assets$728.8M

Cash flow

See full
Operating cash flow$43.1M+775%
CapEx$83.0K+62.7%
Free cash flow$43.0M+782%

Valuation

See full
Market cap$5.37B

Profitability

See full
Gross margin80.8%+1.5pp
Operating margin-85.8%
Net margin-83.9%
FCF margin32.3%

Returns & leverage

See full
Debt / equity0.1×
Current ratio1.3×

Where this comes from

Reported directly by HNGE in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: HNGE’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about HNGE's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is HNGE's investing cash flow?
HNGE (HNGE) reported investing cash flow of $48.08M in Q1 2026.
How has HNGE's investing cash flow changed year-over-year?
HNGE's investing cash flow increased by 325.4% year-over-year, from -$21.33M to $48.08M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.